Boron neutron capture therapy of the rat 9L gliosarcoma: Evaluation of the effects of shark cartilage

British Journal of Radiology

Volumn 73, Issue 868, 2000, Pages 429-434

  Morris, G M ^a   Coderre, J A ^b   Micca, P L ^b   Lombardo, D T ^b   Hopewell, J W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BORONOPHENYLALANINE B 10; ANGIOGENESIS INHIBITOR; ANGIOSTATIN; ENDOSTATIN; FUMAGILLOL CHLOROACETYLCARBAMATE; SHARK CARTILAGE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; GLIOSARCOMA; HISTOPATHOLOGY; NEUTRON CAPTURE THERAPY; NONHUMAN; RAT; SURVIVAL TIME; TUMOR GROWTH; TUMOR MODEL;

EID: 0034016042     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.73.868.10844870     Document Type: Article

References (27)

1. Hawkins MJ. Clinical trials of antiangiogenic agents. Curr Opin Oncol 1995;7:90-3.
2. Eisenstein R, Sargente N, Soble L, et al. The resistance of certain tissues to invasion: penetrability of explanted tissues by vascularised mesenchyme. Am J Pathol 1973;73:765-74.
3. Brem H, Folkman J. Inhibition of tumour angiogenesis mediated by cartilage. J Exp Med 1975;141:427-39.
4. Langer R, Brem H, Falterman K, et al. Isolation of a cartilage factor that inhibits tumour neovascularisation. Science 1976;193:70-2.
5. Langer R, Conn H, Vacanti J, et al. Control of tumour growth in animals by infusion of an angiogenesis inhibitor. Proc Natl Acad Sci USA 1980;77:4331-5.
6. Kuettner KE, Pauli BU. Inhibition of neovascularization by a cartilage factor. Ciba Found Symp 1983;100:163-73.
7. Moses MA, Sudhalter J, Langer R. Identification of an inhibitor of neovascularization from cartilage. Science 1990;248:1408-10.
8. Lee A, Langer R. Shark cartilage contains inhibitors of tumour angiogenesis. Science 1983;221:1185-7.
9. Oikawa T, Ashino-Fuse H, Shimamura M, et al. A novel angiogenic inhibitor derived from Japanese shark cartilage. Extraction and estimation of inhibitory activities toward tumour and embryonic angiogenesis. Cancer Lett 1990;51:181-6.
10. Davis PF, He Y, Furneaux RH, et al. Inhibition of angiogenesis by oral ingestion of powdered shark cartilage in a rat model. Microvasc Res 1997;54: 178-82.
11. Hunt JH, Connelly JF. Shark cartilage for cancer treatment. Am J Health-Syst Pharm 1995;52:1759-60.
12. Teicher BA, Holden SA, Ara G, et al. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other antiangiogenic agents. Int J Cancer 1994; 57:920-5.
13. Coderre JA, Joel DD, Micca PL, et al. Control of intracerebral gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine. Radiat Res 1992;129:290-6.
14. Folkman J. Tumour angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-6.
15. Blackader CB. Sceptics of oral administration of shark cartilage. J Natl Cancer Inst 1993;85:1961-2.
16. Hunt SM, Graff JL. Advanced nutrition and metabolism. In: Gardiner WL, editor. Proteins. New York: West Publishing Co., 1990:129-64.
17. Volopi N. Physico-chemical properties and the structure of dermatan sulphate fractions purified from plasma after oral administration in healthy human volunteers. Thromb Haemost 1996;75:491-6.
18. O'Reilly MS, Holmgren L, Chen CC, et al. Angiostatin induces and sustains dormancy of human primary tumours in mice. Nature Med 1996; 2:689-92.
19. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumour growth. Cell 1997;88:277-85.
20. Isobe N, Uozumi T, Kurizu K, et al. Experimental studies of the antitumour effect of TNP-470 on malignant brain tumours: antitumour effect of TNP-470 on a human medulloblastoma xenograft line. Neuropediatrics 1996;27:136-42.
21. Nagabuchi E, Vanderkolk WE, Une Y, et al. TNP-470 antiangiogenic therapy for advanced murine neuroblastoma. J Pediatric Surg 1997;32:287-93.
22. Teicher BA, Holden SA, Ara G, et al. Influence of an antiangiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy. Int J Cancer 1995;61:732-7.
23. Mauceri HJ, Hanna NN, Beckett MA, et al. Combined effects of angiostatin and ionising radiation in antitumour therapy. Nature 1998;394: 287-91.
24. Pham CD, Roberts TP, van Bruggen N, et al. Magnetic resonance imaging detects supression of tumour vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest 1998;16:225-30.
25. Wittig A, Sauerwein WA, Coderre JA. Transport mechanisms of BPA through the cellular membrane in-vitro. Radiat Res 2000;153:173-80.
26. Morris GM, Coderre JA, Hopewell JW, et al. Response of the central nervous system to boron neutron capture irradiation: evaluation using a rat spinal cord model. Radiother Oncol 1994;32:249-55.
27. 10B from p-boronophenylalanine in a brain tumour model for boron neutron capture therapy. Cancer Res 1996;56:4302-6.